Explore more publications!
Oklahoma Healthcare Wire
Got News to Share?

Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 4, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 4, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season
December 4, 2025

2025 Cannabis Holiday Gift Guide Highlights Canada’s Most Popular Cannabis Products for the Holiday Season

Indeterminate GlobeNewswire
Microbix Announces Initiation of Normal Course Issuer Bid
December 4, 2025

Microbix Announces Initiation of Normal Course Issuer Bid

Indeterminate GlobeNewswire
Atavistik Bio to Present Discovery of JAK2 V617F Mutant-Selective Allosteric Inhibitors for the Treatment of Myeloproliferative Neoplasms (MPNs) at ASH 2025
December 4, 2025

Atavistik Bio to Present Discovery of JAK2 V617F Mutant-Selective Allosteric Inhibitors for the Treatment of Myeloproliferative Neoplasms (MPNs) at ASH 2025

Indeterminate GlobeNewswire
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
December 4, 2025

SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery

Indeterminate GlobeNewswire
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
December 4, 2025

Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement

Indeterminate GlobeNewswire
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
December 4, 2025

MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress

Indeterminate GlobeNewswire
Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors
December 4, 2025

Vaxil Announces Close of Previously Announced Non-Brokered Private Placement and Update on Board of Directors

Indeterminate GlobeNewswire
RadioMedix and Thor Medical enter supply agreement for thorium-228
December 4, 2025

RadioMedix and Thor Medical enter supply agreement for thorium-228

Indeterminate GlobeNewswire
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
December 4, 2025

Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors

Indeterminate GlobeNewswire
Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway
December 4, 2025

Merakris Therapeutics Announces Completion of Type C Meeting with FDA – Alignment on MTX-001 Biologic Drug Development Pathway

Indeterminate GlobeNewswire
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
December 4, 2025

Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics

Indeterminate GlobeNewswire
Communiqué de presse : Sanofi finalise l’acquisition de Vicebio
December 4, 2025

Communiqué de presse : Sanofi finalise l’acquisition de Vicebio

Indeterminate GlobeNewswire
Press Release: Sanofi completes acquisition of Vicebio
December 4, 2025

Press Release: Sanofi completes acquisition of Vicebio

Indeterminate GlobeNewswire
Sapu Nano 推出具有广泛应用前景的 Deciparticle™ 纳米药物平台，可用于多种疏水性肽类、大环内酯类和聚酮类药物的制剂化
December 4, 2025

Sapu Nano 推出具有广泛应用前景的 Deciparticle™ 纳米药物平台，可用于多种疏水性肽类、大环内酯类和聚酮类药物的制剂化

Indeterminate GlobeNewswire
Sapu Nano 推出具有廣泛適用性的 Deciparticle™ 納米醫學平台，能夠製備多種疏水性胜肽類、大環內酯類和聚酮類藥物
December 4, 2025

Sapu Nano 推出具有廣泛適用性的 Deciparticle™ 納米醫學平台，能夠製備多種疏水性胜肽類、大環內酯類和聚酮類藥物

Indeterminate GlobeNewswire
Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing
December 4, 2025

Sapu Nano Announces New PK Data Demonstrating IV Sapu003 Reduces GI Accumulation of Everolimus up to 67-Fold Compared With Oral Dosing

Indeterminate GlobeNewswire
Laigo Bio raises €11.5 million in seed financing to advance its SureTAC™ targeted protein degradation candidates in oncology and auto-immunity
December 4, 2025

Laigo Bio raises €11.5 million in seed financing to advance its SureTAC™ targeted protein degradation candidates in oncology and auto-immunity

Indeterminate GlobeNewswire
Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update
December 4, 2025

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
The Hemp Doctor Introduces THCA Flower Subscription Box — Monthly Curated Rotating Strains, Pre-Rolls & Extras
December 4, 2025

The Hemp Doctor Introduces THCA Flower Subscription Box — Monthly Curated Rotating Strains, Pre-Rolls & Extras

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions